Genmab



Ebitda Veränderung Datum
Agios Pharmaceuticals USD -125797000 20.45M 2025-06
Almirall EUR 76.3M 8.43M 2025-03
Amarin USD -16025000 714K 2025-03
Amgen USD 3.6B 147M 2025-06
argenx SE 288.02M 84.53M 2025-06
AstraZeneca USD 4.96B 127M 2025-06
Bayer EUR 236M 3.35B 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Demant DKK 2.59B 473M 2025-06
Exelixis USD 220.92M 26.71M 2025-06
Fresenius Medical Care EUR 871M 282M 2025-06
Galapagos EUR -158708000 177.84M 2025-03
Genmab DKK 376M 172M 2025-06
GlaxoSmithKline GBP 3.18B 45M 2025-06
GN Store Nord DKK 639M 42M 2025-06
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -297127000 71.11M 2025-06
Lonza CHF 1.01B 139M 2024-12
Merck EUR 1.46B 45M 2025-06
Novartis USD 6.17B 339M 2025-06
Regeneron Pharmaceuticals USD 1.66B 926.5M 2025-06
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 1.89B 971M 2025-06
UCB EUR 1.37B 715M 2024-12


Genmab - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.